Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Conditions
- Nonsmall Cell Lung Cancer Stage III
- Unresectable Non-Small Cell Lung Carcinoma
- Nonsmall Cell Lung Cancer, Stage II
Interventions
- DRUG: Durvalumab
- OTHER: the EORTC Core Quality of Life Questionnaire (EORTC QLQ-C30)
- DIAGNOSTIC_TEST: COPD Assessment Test (CAT)
- DIAGNOSTIC_TEST: Modified Medical Research Council (mMRC) dyspnea scale
Sponsor
Wake Forest University Health Sciences
Collaborators